Stock CARM CARISMA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Carisma Therapeutics, Inc.

Equities

CARM

US14216R1014

Real-time Estimate Cboe BZX
Other stock markets
 12:19:27 2024-05-17 pm EDT 		5-day change 1st Jan Change
1.395 USD +1.82% Intraday chart for Carisma Therapeutics, Inc. -5.74% -52.39%
May. 09 Carisma Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 02 Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer CI

Chart calendar Carisma Therapeutics, Inc.

91ddda.RWqE5uMCDlmfVitMzOlvH9crWkOTlR52JLuko85nFOg.Llriq6g1Iw_QHWUmvJAGLbwaPHvE5kcnT_WV6784R7wND_XQlXd2AM4vcg~62ef0b78828a26a08e0d6de9d1bf5d4c

Upcoming events on Carisma Therapeutics, Inc.

2024-06-01 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No:TPS2682
2024-06-13 10:00 am Annual General Meeting
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-04-07 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)

Past events on Carisma Therapeutics, Inc.

2024-05-13 12:00 pm Citizens JMP Life Sciences Conference
2024-05-09 07:30 am Q1 2024 Earnings Release
2024-05-08 12:00 pm American Society of Gene & Cell Therapy Meeting - Abstract #: 812
2024-05-08 12:00 pm American Society of Gene & Cell Therapy Meeting - Abstract #: 852
2024-04-29 02:00 pm Chardans Genetic Medicines Cell Therapy Manufacturing Summit
2024-04-10 03:45 pm Needham Healthcare Conference
2024-04-09 04:30 pm American Association for Cancer Research Meeting - Abstract Number: 5249
2024-04-01 08:35 am Q4 2023 Earnings Release
2024-03-06 02:50 pm TD Cowen Health Care Conference
2024-01-11 02:15 pm JPMorgan Healthcare Conference
2023-11-29 02:35 pm Evercore ISI HealthCONx Conference
2023-11-09 07:30 am Q3 2023 Earnings Release
2023-11-03 02:30 pm Society for Immunotherapy of Cancer Meeting - Oral – 1514
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - Poster – 389
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - Poster – 635
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - Poster – 307
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - CAR-Macrophages with custom intronic shRNA exhibit enh
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - Engineered Microenvironment Converters
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - Phase 1, First in Human (FIH) study
2023-10-10 07:30 pm Cell & Gene Meeting on the Mesa Conference

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


14,9
13,5
10.27%
15,6

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-88,7
-89,7
1.11%
-62,2

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-86,9
-88,8
2.11%
-57,4

Net income
Million USD		Released
Forecast
Spread 		-61,2


-86,9
-88,9
2.28%
-57,4

EPS
USD		Released
Forecast
Spread 		-54,7


-2,59
-2,52
-2.68%
-1,26

Announcement Date04/04/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		3,24
3,73
-13.08%		3,56
3,24
9.77%		3,83
0,89
330%		4,29
2,91
47.55%		3,40
4,40
-22.73%
3,92


4,30


3,90


2,40


2,40

EBIT
Million USD		Released
Forecast
Spread 		-23,0
-17,0
-35.03%		-21,0
-23,6
11.35%		-22,3
-23,4
4.56%		-22,5
-23,4
4.13%		-19,5
-19,5
0.04%
-14,4


-13,8


-14,5


-11,9


-13,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-24,5
-18,4
-33.12%		-19,8
-22,8
13.24%		-21,4
-23,0
6.82%		-21,2
-22,9
7.57%		-19,0
-16,9
-12.23%
-13,0


-12,4


-13,1


-11,3


-12,5

Net income
Million USD		Released
Forecast
Spread 		-24,6
-18,4
-33.71%		-19,9
-24,0
17.09%		-21,4
-23,0
6.82%		-21,0
-22,9
8.43%		-19,0
-17,2
-10.15%
-13,0


-12,4


-13,1


-11,3


-12,5

EPS
USD		Released
Forecast
Spread 		-1,93
-0,89
-116.85%		-0,49
-0,60
17.88%		-0,53
-0,57
7.02%		-0,48
-0,55
13.12%		-0,46
-0,43
-6.36%
-0,30


-0,27


-0,27


-0,31


-0,33

Announcement Date11/05/2310/08/2309/11/2301/04/2409/05/24-----

Upcoming sector events for Carisma Therapeutics, Inc.

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Carisma Therapeutics, Inc.

Today 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-15 04:01 pm CELCUITY INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 08:00 am IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CARM Stock
  4. Calendar Carisma Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW